136 related articles for article (PubMed ID: 12924447)
1. Genetic and epigenetic alterations in tumor progression in a dedifferentiated chondrosarcoma.
Röpke M; Boltze C; Neumann HW; Roessner A; Schneider-Stock R
Pathol Res Pract; 2003; 199(6):437-44. PubMed ID: 12924447
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis.
Bovée JV; Cleton-Jansen AM; Rosenberg C; Taminiau AH; Cornelisse CJ; Hogendoorn PC
J Pathol; 1999 Dec; 189(4):454-62. PubMed ID: 10629543
[TBL] [Abstract][Full Text] [Related]
3. Mutation of p53 with loss of heterozygosity in the osteosarcomatous component of a dedifferentiated chondrosarcoma.
Grote HJ; Schneider-Stock R; Neumann W; Roessner A
Virchows Arch; 2000 May; 436(5):494-7. PubMed ID: 10881744
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression.
van Beerendonk HM; Rozeman LB; Taminiau AH; Sciot R; Bovée JV; Cleton-Jansen AM; Hogendoorn PC
J Pathol; 2004 Mar; 202(3):359-66. PubMed ID: 14991902
[TBL] [Abstract][Full Text] [Related]
5. Rb-loss is associated with high malignancy in chondrosarcoma.
Röpke M; Boltze C; Meyer B; Neumann HW; Roessner A; Schneider-Stock R
Oncol Rep; 2006 Jan; 15(1):89-95. PubMed ID: 16328039
[TBL] [Abstract][Full Text] [Related]
6. Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
Zöchbauer-Müller S; Fong KM; Virmani AK; Geradts J; Gazdar AF; Minna JD
Cancer Res; 2001 Jan; 61(1):249-55. PubMed ID: 11196170
[TBL] [Abstract][Full Text] [Related]
7. H-ras oncogene mutation in dedifferentiated chondrosarcoma: polymerase chain reaction-restriction fragment length polymorphism analysis.
Sakamoto A; Oda Y; Adachi T; Oshiro Y; Tamiya S; Tanaka K; Matsuda S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2001 Apr; 14(4):343-9. PubMed ID: 11301351
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity and DNA ploidy point to a diverging genetic mechanism in the origin of peripheral and central chondrosarcoma.
Bovée JV; Cleton-Jansen AM; Kuipers-Dijkshoorn NJ; van den Broek LJ; Taminiau AH; Cornelisse CJ; Hogendoorn PC
Genes Chromosomes Cancer; 1999 Nov; 26(3):237-46. PubMed ID: 10502322
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinoma arising in dedifferentiated chondrosarcoma proved by isocitrate dehydrogenase mutation analysis.
Zhang Y; Paz Mejia A; Temple HT; Trent J; Rosenberg AE
Hum Pathol; 2014 Jul; 45(7):1541-5. PubMed ID: 24792622
[TBL] [Abstract][Full Text] [Related]
10. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
11. Methylation status of EXT1 and EXT2 promoters and two mutations of EXT2 in chondrosarcoma.
Tsuchiya T; Osanai T; Ogose A; Tamura G; Chano T; Kaneko Y; Ishikawa A; Orui H; Wada T; Ikeda T; Namba M; Takigawa M; Kawashima H; Hotta T; Tsuchiya A; Ogino T; Motoyama T
Cancer Genet Cytogenet; 2005 Apr; 158(2):148-55. PubMed ID: 15796962
[TBL] [Abstract][Full Text] [Related]
12. Genetic and epigenetic alterations of 9p21 gene products in benign and malignant tumors of the head and neck.
Weber A; Wittekind C; Tannapfel A
Pathol Res Pract; 2003; 199(6):391-7. PubMed ID: 12924439
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q.
Bello MJ; Amiñoso C; Lopez-Marin I; Arjona D; Gonzalez-Gomez P; Alonso ME; Lomas J; de Campos JM; Kusak ME; Vaquero J; Isla A; Gutierrez M; Sarasa JL; Rey JA
Acta Neuropathol; 2004 Nov; 108(5):413-21. PubMed ID: 15365725
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas.
Yamaguchi T; Toguchida J; Wadayama B; Kanoe H; Nakayama T; Ishizaki K; Ikenaga M; Kotoura Y; Sasaki MS
Anticancer Res; 1996; 16(4A):2009-15. PubMed ID: 8712735
[TBL] [Abstract][Full Text] [Related]
16. [Studies of promoter methylation status and protein expression of E-cadherin gene in associated progression stages of gastric cancer].
Zheng ZH; Sun XJ; Ma MC; Hao DM; Liu YH; Sun KL
Yi Chuan Xue Bao; 2003 Feb; 30(2):103-8. PubMed ID: 12776596
[TBL] [Abstract][Full Text] [Related]
17. [Promotor hypermethylation of E-cadherin, p16 and estrogen receptor in prostate carcinoma].
Yao Q; He XS; Zhang JM; He J
Zhonghua Nan Ke Xue; 2006 Jan; 12(1):28-31. PubMed ID: 16483154
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways.
Murao K; Kubo Y; Ohtani N; Hara E; Arase S
Br J Dermatol; 2006 Nov; 155(5):999-1005. PubMed ID: 17034532
[TBL] [Abstract][Full Text] [Related]
19. Two-hit inactivation of FHIT by loss of heterozygosity and hypermethylation in breast cancer.
Yang Q; Nakamura M; Nakamura Y; Yoshimura G; Suzuma T; Umemura T; Shimizu Y; Mori I; Sakurai T; Kakudo K
Clin Cancer Res; 2002 Sep; 8(9):2890-3. PubMed ID: 12231533
[TBL] [Abstract][Full Text] [Related]
20. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.
Goel A; Nagasaka T; Arnold CN; Inoue T; Hamilton C; Niedzwiecki D; Compton C; Mayer RJ; Goldberg R; Bertagnolli MM; Boland CR
Gastroenterology; 2007 Jan; 132(1):127-38. PubMed ID: 17087942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
